Autologous dendritic cell transplantation as an adjuvant treatment in pleomorphic lung carcinoma
Acta Medica Philippina
; : 72-75, 2013.
Article
in English
| WPRIM (Western Pacific)
| ID: wpr-633720
Responsible library:
WPRO
ABSTRACT
We embarked on autologous dendric cells (DC) transplantation as an adjuvant therapy with chemotherapy in a pleomorphic lung carcinoma patient. DC were isolated from PBMC and primed with the autologous tumor lysate. No adverse event was noted in DC transplantation. DC administration also correlated with immunomodulation, as evidenced by an approximately 5-fold increase in serum interferon gamma after 2 months. The utility of autologous DC transplantation may offer a clinical benefit with virtually no adverse event.
Full text:
Available
Database:
WPRIM (Western Pacific)
Main subject:
Transplantation, Autologous
/
Leukocytes, Mononuclear
/
Interferon-gamma
/
Combined Modality Therapy
/
Immunomodulation
/
Neoplasms
Limits:
Adult
/
Humans
/
Male
Language:
English
Journal:
Acta Medica Philippina
Year:
2013
Document type:
Article